Back to today’s briefing

Story perspectives

New Study Reveals Key to Alzheimer's Treatment Breakthrough

6/13/2025

25 3

Summary

Story summary

In a groundbreaking study, scientists from the Wellcome Sanger Institute analyzed 140,000 variations of the A?42 peptide, uncovering crucial interactions that influence amyloid protein aggregation in Alzheimer's disease. Their findings hold promise for developing targeted therapies, offering hope to the 55 million people worldwide affected by this devastating condition.

1 of 1

Story summary

In a groundbreaking study, scientists from the Wellcome Sanger Institute analyzed 140,000 variations of the A?42 peptide, uncovering crucial interactions that influence amyloid protein aggregation in Alzheimer's disease. Their findings hold promise for developing targeted therapies, offering hope to the 55 million people worldwide affected by this devastating condition.